Latest News & Features
Americas
Biopharmaceutical company Omeros has filed a complaint against Sandoz for allegedly infringing its patent covering Omidria. 23 June 2017
Americas
Earlier this month, the US Supreme Court handed down its decision in the biosimilars battle between Amgen and Sandoz, centring on the Biologics Price Competition and Innovation Act. 23 June 2017
Americas
GSK has won a patent case against Teva in which the company will receive $235 million in damages. 22 June 2017
Americas
“There’s one stick with this carrot—the whistleblower protection law,” explained Anne Elise Li, IP counsel at Crowell & Moring, in reference to the Defend Trade Secrets Act. 22 June 2017
Americas
The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent sub-ject matter eligibility. 22 June 2017
Europe
Collaboration and sharing are important goals for Bayer in seeking to protect innovations with IP rights, as Richard Rees explains in an interview with LSIPR. 22 June 2017
Big Pharma
Panellists discussed the potential impact of the UK’s decision to leave the EU on patents yesterday at the 2017 BIO International Convention. 22 June 2017
Africa
Pfizer and Takeda have joined together with non-profit BIO Ventures for Global Health and the African Organisation for Research and Training in Cancer to launch the African Access Initiative. 22 June 2017
Americas
Academic patents and their subsequent licensing contributed up to $1.3 trillion to US industry gross output between 1996 and 2015, the Biotechnology Innovation Organization has found. 22 June 2017
Americas
Florida-based company Belcher Pharmaceuticals has filed a complaint against Hospira for patent infringement. 21 June 2017